SKF 104078
Latest Information Update: 23 Sep 1997
Price :
$50 *
At a glance
- Originator GlaxoSmithKline
- Class Antihypertensives
- Mechanism of Action Alpha 1 adrenergic receptor antagonists; Alpha 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension